[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Mufaso [@Mufaso7](/creator/twitter/Mufaso7) on x 3235 followers Created: 2025-07-20 10:46:32 UTC Lots of evidence that GLP1's have positive effects beyond Obesity/T2D. Importantly, it sure seems like whenever there is a study evaluating other indications, dual agonist GLP1/GIP wins every time vs mono agonist GLP1. 🤔 Here is a link to a recent study on Parkinson's: $LLY $VKTX XXXXX engagements  **Related Topics** [$lly](/topic/$lly) [eli lilly](/topic/eli-lilly) [stocks healthcare](/topic/stocks-healthcare) [$vktx](/topic/$vktx) [Post Link](https://x.com/Mufaso7/status/1946884424026493064)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Mufaso @Mufaso7 on x 3235 followers
Created: 2025-07-20 10:46:32 UTC
Lots of evidence that GLP1's have positive effects beyond Obesity/T2D. Importantly, it sure seems like whenever there is a study evaluating other indications, dual agonist GLP1/GIP wins every time vs mono agonist GLP1. 🤔 Here is a link to a recent study on Parkinson's:
$LLY $VKTX
XXXXX engagements
Related Topics $lly eli lilly stocks healthcare $vktx
/post/tweet::1946884424026493064